Articles

Plain explanations of what these assessments measure, written for the person having them and for the clinician reading the report.

  • Remitted Depression and Cognitive Decline: A Screening Trigger

    Remitted Depression and Cognitive Decline: A Screening Trigger Remitted depression is a screening trigger for cognitive decline: in one cohort of older adults whose depression had lifted, about one in four developed dementia within five years. That history is a reason to set a standardized cognitive baseline and follow it. Remission ends the mood episode,…

    Read the article

  • Body Fat Distribution and Dementia Risk: Screening Beyond the Scale

    Body Fat Distribution and Dementia Risk: Screening Beyond the Scale Body fat distribution shifts dementia risk: among 412,691 UK Biobank adults, a central fat pattern and fat concentrated in the arms each predicted more neurodegenerative disease, and muscle strength predicted less. Where fat sits and how much muscle surrounds it predicted neurodegenerative disease in a…

    Read the article

  • Modifiable Risk Factors for Dementia: What Primary Care Can Measure

    Modifiable Risk Factors for Dementia: What Primary Care Can Measure Primary care can measure four of the 14 modifiable dementia risk factors in the 2024 Lancet Commission with a number: blood pressure, glucose regulation, LDL cholesterol and adiposity. The others have to be asked about, and some were settled long before the visit. A population…

    Read the article

  • Ketones as Brain Fuel: The Entrance Insulin Resistance Cannot Close

    Ketones as Brain Fuel: The Entrance Insulin Resistance Cannot Close Ketones fuel the brain without insulin: they enter nerve cells through carriers that depend on neither insulin nor the GLUT4 glucose transporter. When insulin resistance closes part of the glucose supply to the memory circuits, ketones still get in. The memory circuits partly depend on…

    Read the article

  • Brain Insulin Resistance in Alzheimer Disease: Why Type 3 Diabetes

    Brain Insulin Resistance in Alzheimer Disease: Why Type 3 Diabetes Brain insulin resistance in Alzheimer disease means the brain both makes less insulin and stops answering it, a pattern found in donated brain tissue even from people without diabetes. That is why the disease was named type 3 diabetes. The label came from pathologists holding…

    Read the article

  • Gut Bacteria, Stress and the Clock Your Body Runs On

    Gut Bacteria, Stress and the Clock Your Body Runs On Gut bacteria help set the daily rhythm of your stress response, which runs highest around waking and lowest at night. In mice, removing gut bacteria left the stress hormone released at the wrong times of day, not in the wrong amount. The same bad news…

    Read the article

  • Metabolic Osteoarthritis: Screening the Hand and Younger Joint

    Metabolic Osteoarthritis: Screening the Hand and Younger Joint Metabolic osteoarthritis screening belongs in two presentations: osteoarthritis in the finger joints, which carry almost no load, and osteoarthritis that starts unexpectedly young. In both, a glycemic, insulin and lipid panel is the right first test. Load explains the knee. It does not explain the interphalangeal joint,…

    Read the article

  • Sugar and Gum Inflammation: The Gauge in Your Mouth

    Sugar and Gum Inflammation: The Gauge in Your Mouth Sugar drives gum inflammation: young adults eating the most added sugar had about 1.42 times the rate of gum disease, and cutting refined carbohydrate cut gum bleeding by more than half while plaque stayed the same. Your gums are the only inflamed tissue you can look…

    Read the article

  • The Endothelial Glycocalyx: The Lining Sugar Strips First

    The Endothelial Glycocalyx: The Lining Sugar Strips First The endothelial glycocalyx is the soft gel lining the inside of your arteries that keeps blood cells from sticking, holds fluid inside the vessel and tells the artery when to widen. The inside of an artery is coated in a soft gel that decides how blood flows…

    Read the article

  • Screening for Cirrhosis in Dementia: The Encephalopathy in the Chart

    Screening for Cirrhosis in Dementia: The Encephalopathy in the Chart Screening for cirrhosis in dementia means computing a FIB-4 index from values already in the chart. In two national cohorts, 5% to 13% of patients with dementia had scores pointing to undiagnosed advanced fibrosis or cirrhosis, and hepatic encephalopathy, unlike most dementia, responds to treatment.…

    Read the article